VRTX | 7.85% | 467.22 | -0.52% | 918,183 | |
AMGN | 7.81% | 303.57 | -0.98% | 1,408,436 | |
GILD | 7.51% | 113.90 | -1.98% | 3,687,172 | |
REGN | 6.63% | 565.42 | +0.41% | 645,631 | |
ALNY | 4.52% | 329.48 | +0.20% | 773,491 | |
IQV | 3.71% | 200.28 | +0.56% | 1,064,012 | |
MTD | 2.89% | 1,267.82 | +0.30% | 128,373 | |
argenx SE ADR | - | 2.46% | - | - | 238,821 |
BIIB | 2.13% | 130.40 | -0.85% | 907,512 | |
INSM | 2.05% | 103.09 | -0.83% | 1,104,134 |
iShares Trust - iShares Biotechnology ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. It invests in stocks of companies operating across biotechnology sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE Biotechnology Index, by using representative sampling technique. iShares Trust - iShares Biotechnology ETF was formed on February 5, 2001 and is domiciled in the United States.